Eli Lilly Announces 3.5 Billion Dollar Investment in New Pennsylvania Manufacturing Facility

Eli Lilly announced plans to build a pharmaceutical facility in Pennsylvania to produce weight-loss drugs. The project will create at least 850 local jobs.

Insights:
Eli Lilly and Company announced it will build a $3.5 billion pharmaceutical manufacturing facility in the Lehigh Valley region of Pennsylvania. This new site will focus on the production of the company’s injectable weight-loss medications, including retatrutide. The project represents the largest investment by a life sciences company in the history of Pennsylvania.
FILE PHOTO: The Eli Lilly logo is displayed on one of the company's offices in San Diego, California, U.S., on September 17, 2020. REUTERS/Mike Blake/File Photo
FILE PHOTO: The Eli Lilly logo is displayed on one of the company's offices in San Diego, California, U.S., on September 17, 2020. REUTERS/Mike Blake/File Photo